amobarbital has been researched along with Dyskinesia, Medication-Induced in 1 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighty-six patients with acute psychotic exacerbations were treated with fixed dosage regimens of oral fluphenazine up to 10-30 mg/day in randomized, double-blind studies." | 2.67 | Acute dystonia during fixed-dose neuroleptic treatment. ( Friedman, E; Levinson, DF; Lo, ES; Simpson, GM; Singh, H, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, H | 1 |
| Levinson, DF | 1 |
| Simpson, GM | 1 |
| Lo, ES | 1 |
| Friedman, E | 1 |
1 trial available for amobarbital and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Acute dystonia during fixed-dose neuroleptic treatment.
Topics: Adult; Amobarbital; Chloral Hydrate; Dose-Response Relationship, Drug; Drug Administration Schedule; | 1990 |